Transdermal Patches for Delivery of Beta-Blockers

[1] Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Akhtar N, Raish M, Aqil M. Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharm J. 2015;23(6):587–602. AhadA Al-JenoobiFI Al-MohizeaAM AkhtarN RaishM AqilM Systemic delivery of β-blockers via transdermal route for hypertension Saudi Pharm J 2015 23 6 587 602 10.1016/j.jsps.2013.12.019 Search in Google Scholar

[2] Aqil M, Sultana Y, Ali A. Transdermal delivery of β-blockers. Expert Opin Drug Deliv. 2006;3(3):405–18. AqilM SultanaY AliA Transdermal delivery of β-blockers Expert Opin Drug Deliv 2006 3 3 405 18 10.1517/17425247.3.3.405 Search in Google Scholar

[3] Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91(9):2076–89. AroraP MukherjeeB Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt J Pharm Sci 2002 91 9 2076 89 10.1002/jps.10200 Search in Google Scholar

[4] Calatayud-Pascual MA, Sebastian-Morelló M, Balaguer-Fernández C, Delgado-Charro MB, López-Castellano A, Merino V. Influence of chemical enhancers and iontophoresis on the in vitro transdermal permeation of propranolol: Evaluation by dermatopharmacokinetics. Pharmaceutics. 2018;10(4). Calatayud-PascualMA Sebastian-MorellóM Balaguer-FernándezC Delgado-CharroMB López-CastellanoA MerinoV Influence of chemical enhancers and iontophoresis on the in vitro transdermal permeation of propranolol: Evaluation by dermatopharmacokinetics Pharmaceutics 2018 10 4 10.3390/pharmaceutics10040265 Search in Google Scholar

[5] Costa P, Sousa Lobo JM. Modeling and Comparison of Dissolution Profiles. Eur J Pharm Sci. 2001;13(2):123–133. CostaP Sousa LoboJM Modeling and Comparison of Dissolution Profiles Eur J Pharm Sci 2001 13 2 123 133 10.1016/S0928-0987(01)00095-1 Search in Google Scholar

[6] Dey BK, Kar PK, Nath LK. Formulation design, preparation and in vitro – in vivo evaluation of propranolol hydrochloride transdermal patches using hydrophilic and hydrophobic polymer complex. Research J. Pharm. and Tech. 2009;2(1):155–160. DeyBK KarPK NathLK Formulation design, preparation and in vitro – in vivo evaluation of propranolol hydrochloride transdermal patches using hydrophilic and hydrophobic polymer complex Research J. Pharm. and Tech. 2009 2 1 155 160 Search in Google Scholar

[7] European pharmacopoeia 10.4. 2.9.4. Dissolution test for transdermal patches. (https://pheur.edqm.eu/app/10-4/content/10-4/20904E.htm?highlight=on&terms=dissolution). Revised April 2021. Accessed June 7, 2021. European pharmacopoeia 10.4. 2.9.4. Dissolution test for transdermal patches (https://pheur.edqm.eu/app/10-4/content/10-4/20904E.htm?highlight=on&terms=dissolution). Revised April 2021. Accessed June 7, 2021. Search in Google Scholar

[8] Levis SR, Deasy PB. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int J Pharm. 2003;253(1–2):145–57. LevisSR DeasyPB Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride Int J Pharm 2003 253 1–2 145 57 10.1016/S0378-5173(02)00702-0 Search in Google Scholar

[9] Sanap GS, Dama GY, Hande AS et al. Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int J Green Pharm. 2008;2(2):129. SanapGS DamaGY HandeAS Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer Int J Green Pharm 2008 2 2 129 10.4103/0973-8258.41189 Search in Google Scholar